Document is current
Any future updates will be listed below
-
Authors
Sener, Ugur https://orcid.org/0000-0002-3919-7408
Wilcox, Jessica A. https://orcid.org/0000-0002-2919-1360
Boire, Adrienne A. https://orcid.org/0000-0002-9029-1248
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1 TR002377)
National Cancer Institute (P30 CA008748, P30 CA008748)
- License Information
-
More Information
Article History
Accepted: 2 March 2025
First Online: 18 March 2025
Declarations
:
: This publication was supported by Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS) to Ugur Sener.This work was supported by National Institute of Health/National Cancer Institute P30 CA008748 and 1R01CA245499-01A1 to Adrienne A. Boire.
: • Ugur Sener reports: Servier (Mayo Clinic Glioma Center of Excellence Advisory Board – paid).• Adrienne Boire reports: Evren Technologies (scientific advisory board - unpaid), Apellis Pharmaceuticals (consultant), Patents (inventor) via Sloan Kettering Institute..
